## Anti -CD3 Ψ anti-B-cell antigen bispecific monoclonal antibodies (bsAbs) can redirect T-cell-mediated lysis toward malignant B cells. Clinical trials with CD3-based bsAbs have shown toxicity in patients which is likely related to nonspecific T-cell activation and targeting. Our current studies
Human in vivo antigenic modulation induced by the anti-T cell OKT3 monoclonal antibody
β Scribed by Lucienne Chatenoud; Marc F. Baudrihaye; Henri Kreis; Gideon Goldstein; John Schindler; Jean-Francois Bach
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- English
- Weight
- 345 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The antiβpan T cell monoclonal antibody OKT3 was administered daily for 2 weeks in four human renal allograft recipients. The antibody induced a dramatic and immediate depletion of peripheral T cells followed by an in vivo antigenic modulation of the OKT3βdefined membrane antigen: after three injections, OKT3βtreated patients showed a limited but significant number of OKT3^β^ cells of T cell nature (as defined by OKT4 and OKT8) which recovered the OKT3 receptor after an overnight in vitro incubation in the absence of the monoclonal antibody.
π SIMILAR VOLUMES
In many tissues, the TF (Thomsen-Friedenreich) blood group antigen (Galβ€1-3GalNAcβ£-) behaves as an onco-foetal carbohydrate antigen, showing increased expression in malignancy and hyperplasia. Dietary lectins which bind the TF antigen have marked effects on proliferation of epithelial cells without